(DBXS) Xtrackers - Switzerland - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0274221281 • Switzerland Equity
DBXS: Swiss, Stocks, Bonds, Equities, ETFs
Xtrackers - Switzerland UCITS ETF (DBXS) is a Germany-domiciled exchange-traded fund designed to provide exposure to the Swiss equity market. It tracks the Morningstar Switzerland Target Market Exposure Net CHF Index, which offers a broad representation of Swiss companies. The fund is listed on XETRA, making it accessible to European investors seeking Swiss market exposure.
With an AUM of 1.34 billion euros, this ETF is backed by DWS, a well-established asset manager with a strong track record in ETFs. The fund employs a replication strategy, aiming to closely track the performance of its underlying index. Its expense ratio is competitive, aligning with the cost-efficient nature of Xtrackers products.
The Morningstar Switzerland TME NR CHF Index includes large-, mid-, and small-cap companies, ensuring diversification across market capitalizations. The index is rebalanced periodically to maintain its target exposure. As a UCITS-compliant fund, DBXS adheres to strict regulatory standards, ensuring transparency and investor protection.
Investors in DBXS gain access to key Swiss sectors, including financials, healthcare, and industrials, which are pivotal to Switzerlands economy. The funds CHF-denominated returns are appealing to investors seeking Swiss franc exposure. Its liquidity is supported by XETRA, one of Europes major exchanges, ensuring efficient trading.
For fund managers and investors, DBXS serves as a tool for Swiss equity allocation without the need for individual stock selection. Its structure simplifies accessing the Swiss market, known for its stability and multinational corporations. The fund is suitable for both strategic allocations and tactical shifts, offering flexibility in portfolio construction.
Additional Sources for DBXS ETF
DBXS ETF Overview
Market Cap in USD | 1,538m |
Category | Switzerland Equity |
TER | 0.31% |
IPO / Inception | 2007-01-22 |
DBXS ETF Ratings
Growth Rating | 52.8 |
Fundamental | - |
Dividend Rating | 50.9 |
Rel. Strength | -9.86 |
Analysts | - |
Fair Price Momentum | 126.15 EUR |
Fair Price DCF | - |
DBXS Dividends
Dividend Yield 12m | 1.58% |
Yield on Cost 5y | 2.18% |
Annual Growth 5y | 4.32% |
Payout Consistency | 91.7% |
DBXS Growth Ratios
Growth Correlation 3m | -18.9% |
Growth Correlation 12m | 39.7% |
Growth Correlation 5y | 85.4% |
CAGR 5y | 6.37% |
CAGR/Max DD 5y | 0.38 |
Sharpe Ratio 12m | 1.25 |
Alpha | 1.86 |
Beta | 0.441 |
Volatility | 28.32% |
Current Volume | 4.7k |
Average Volume 20d | 15.2k |
As of April 22, 2025, the stock is trading at EUR 128.90 with a total of 4,728 shares traded.
Over the past week, the price has changed by +0.59%, over one month by -7.59%, over three months by -1.48% and over the past year by +6.35%.
Partly, yes. Based on ValueRay Analyses, Xtrackers - Switzerland (XETRA:DBXS) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 52.81 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXS as of April 2025 is 126.15. This means that DBXS is currently overvalued and has a potential downside of -2.13%.
Xtrackers - Switzerland has no consensus analysts rating.
According to ValueRays Forecast Model, DBXS Xtrackers - Switzerland will be worth about 137.4 in April 2026. The stock is currently trading at 128.90. This means that the stock has a potential upside of +6.56%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 137.4 | 6.6% |